Stay updated with breaking news from Axio Biosolutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
[Report of 250 Pages] In 2022, the market for products for wound debridement is anticipated to be worth US$ 497.3 billion. The overall demand for wound debridement products is anticipated to increase at a CAGR of 5.6% between 2022 and 2032, reaching approximately US$ 857.55 Billion by 2032 due to the rise in the inc...
The National Medical Devices Policy 2023 announcement by the Centre has delighted city-based biomedical device...
Chronic wound care management is more than just dressing change or bandaging. Let’s look at some of the latest developments in wound care management. TheHealthSite.com
Get Injuries latest news, Article video and Photos on Injuries Explore latest health updates, news, information from TheHealthSite.com
Ax-Surgi Surgical Hemostat, a chitosan-based hemostat for controlling severe surgical bleeding, developed by Axio Biosolutions, has received the US Food and Drug Administration (FDA) 510(k) clearance. TheHealthSite.com